Building a tuberculosis-free world: The Lancet Commission on tuberculosis
Citation: Reid, M. J. A., Arinaminpathy, N., Bloom, A., Bloom, B. R., Boehme, C., Chaisson, R., Chin, D. P., Churchyard, G., Cox, H., Ditiu, L., Dybul, M., Farrar, J., Fauci, A. S., Fekadu, E., Fujiwara, P. I., Hallett, T. B., Hanson, C. L., Harrington, M., Herbert, N., … Goosby, E. P. (2019). Building a tuberculosis-free world: The Lancet Commission on tuberculosis. The Lancet, 393(10178), 1331–1384. https://doi.org/10.1016/S0140-6736(19)30024-8
Abstract: Tuberculosis can be treated, prevented, and cured. Rapid, sustained declines in tuberculosis deaths in many countries during the past 50 years provide compelling evidence that ending the pandemic is feasible. Yet this disease—which has plagued humanity since before recorded history and has killed hundreds of millions of people over the past two centuries—remains a relentless scourge. In 2017, 1·6 million people died from tuberculosis, including 300 000 people with HIV, representing more deaths than any other infectious disease. Moreover, in many parts of the world, drug-resistant forms of tuberculosis threaten struggling control efforts. The world can no longer ignore the enormous pall cast by the tuberculosis epidemic. Going forward, the global tuberculosis response must be an inclusive, comprehensive response within the broader sustainable development agenda. No one-size-fits-all approach can succeed.
Author(s): The Lancet
Resource Type: Journal Articles
Filed under: Assessment, Drug-resistant TB, End TB, Journal Article, Mortality, Prevention, Research, Treament